Washington, D.C.—The Council for Responsible Nutrition (CRN), in light of COVID-19, moved their annual Day on the Hill federal advocacy event to an online drive, according to a press release. The Supplement Advocacy Send-In encouraged member companies to contact congressional representatives about industry issues. One issue in particular: cannabidiol and...
Washington, D.C.—The Natural Products Association (NPA) announced that it has submitted comments to the Food and Drug Administration (FDA) regarding “Food Standards; General Principles and Food Standards Modernization.” NPA's message: The Agency needs to do more to stop fraudulent products from entering the U.S. One of NPA's concerns: “economic adulteration"—firms replacing...
Silver Spring, MD—FDA is preparing to resume domestic inspections, according to a statement from Stephen M. Hahn, M.D., Commissioner of FDA. The agency is currently looking to restart on-site inspections the week of July 20, but notes that this will depend on the virus’ trajectory in a given state and...
Washington, D.C.—FDA has sent to Congress their report on the current state of the cannabidiol (CBD) marketplace. The report recognizes the public’s interest in CBD, but says that “there are many questions about the characteristics of currently marketed CBD products because the Agency lacks significant information on what CBD-containing products...
Washington, D.C.—The State of Hawaii recently proposed new state regulations for consumable hemp and cannabidiol (CBD) products, according to a statement from the Natural Products Association (NPA), which notes that Hawaii is the latest state to try and fill the “vacuum” left by FDA’s decision not to regulate CBD; Texas...
Washington, D.C.—The Natural Products Association (NPA) reported that, during an NPA webinar on June 23, state regulators "sounded off" on the Food and Drug Administration (FDA) for its inaction on cannabidiol (CBD) products. As WholeFoods previously reported, prior to the webinar, NPA had invited FDA to elaborate on the “substantial progress”...
Washington, D.C.—The Council for Responsible Nutrition (CRN) has submitted a Citizen’s Petition to FDA, requesting that the agency establish a regulatory pathway to legally market dietary supplements containing hemp-derived cannabidiol (CBD), according to a press release. The petition formally calls on FDA to take action, and to exercise the statutory...
Silver Spring, MD—The American Herbal Products Association (AHPA) has released its analysis of 135 COVID-19 related warning letters that were issued by either the Food and Drug Administration (FDA), the Federal Trade Commission (FTC), or by the agencies jointly between March 6, 2020, and May 11, 2020. “The regulated dietary...
Washington, D.C.—The Collaborative for CBD Science and Safety (CCSS)—which provides a forum for industry, researchers, academia, healthcare practitioners, and regulators to exchange information and respond to policies and practices affecting cannabidiol (CBD) research, safety and quality—is calling on stakeholders to accelerate both research and the development of a federal regulatory...
Washington, D.C.—The Natural Products Association (NPA) has invited the Food and Drug Administration (FDA) to elaborate on the “substantial progress” FDA said it has made on developing regulatory guidance for cannabidiol (CBD) products. NPA explained in a press release that an FDA spokesperson told Food Navigator-USA that the Agency is...
